AI assistant
Sending…
Clene Inc. — Director's Dealing 2026
Feb 20, 2026
34487_dirs_2026-02-20_fdde9dd8-1c9a-4f4a-9e04-c177b10e5c39.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Clene Inc. (CLNN)
CIK: 0001822791
Period of Report: 2026-02-19
Reporting Person: Desai Arjun JJ (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 | stock option | $4.73 | A | 3168 | Acquired | 2036-02-18 | common stock (3168) | Direct |
Footnotes
F1: This option was granted on February 19, 2026 as an option for 3,168 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant.
More from Clene Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 4
Annual Report
2026
Mar 17
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 20